Baker Hughes (BHI) was downgraded to hold from buy at GMP Securities. Consensus earnings estimates appear too high, GMP said.
CalAtlantic (CAA) was upgraded to buy from neutral at MKM Partners. $47 price target. The company is positioned well and offers good value, MKM said.
Chubb (CB - Get Report) was downgraded to market perform at BMO Capital. $136 price target. The valuation is less attractive, as the stock has outperformed the market by 25% over the past year, BMO said.
DSW (DSW) was upgraded to market perform from underperform at Wells Fargo. The company lacks near-term potential downside catalysts, Wells said.
Horizon Pharma (HZNP - Get Report) was upgraded to equal-weight from underweight at Morgan Stanley. $24 price target. The company is inexpensive and has multiple potential catalysts, Morgan Stanley said.